• vcard
  • Education
    • J.D., Washington University-St. Louis School of Law, 2007, Executive Board, Washington University Law Review, 2006-2007
    • B.S./B.A., University of Nebraska, 2004, with highest distinction, Chancellor's Scholar

Whether it's closing an acquisition of a large business or providing legal counsel on day-to-day operations, Andrew Kinworthy strives to provide clients with the highest possible level of legal service. He is committed to helping clients achieve their goals and has considerable experience representing public and private companies in complex mergers, acquisitions, joint ventures, divestitures, and similar complex business transactions. He regularly assists clients in various debt and equity financing and venture capital transactions and advises clients regarding all aspects of the business lifecycle, including formation, operation, financing, compliance, dissolution and liquidation, sale of the business, and similar matters.

  • Assisted in representation of one of the largest health systems in the United States in a strategic joint venture transaction with a health care technology company involving the transfer of more than $6 billion in patient revenue to their revenue cycle management platform and a minority equity investment.
  • Lead associate in representation of one of the largest health systems in the United States in its $6 million venture capital investment in a virtual health care company.
  • Lead associate in representation of a manufacturing company in its strategic acquisition of a competitor for $85 million in cash and equity.
  • Lead associate in representation of a chain of retail pharmacy stores in the sale of its business to CVS Caremark Corporation for $51 million.
  • Lead associate in representation of a middle market manufacturing company in the reorganization and recapitalization of its affiliated group of companies for a total transaction value of approximately $15 million.
  • Assisted in representation of a Berkshire Hathaway portfolio company in a $42 million strategic acquisition of a competitor.
  • Assisted in representation of a public company in negotiations with a potential strategic acquirer to sell certain assets for more than $150 million.
Publications & Presentations
To Remedy or Not to Remedy: The Availability of Disgorgement Under Civil RICO
Washington Law Review, Vol. 84:969
Upcoming Events